Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer.

Abstract

Male breast cancer is an uncommon occurrence. Treatment of male breast cancer is typically extrapolated from data on the treatment of female breast cancer. Recently, aromatase inhibition has been proven as an effective therapy for female breast cancer, particularly in the setting of advanced cancers. The efficacy of aromatase inhibitors in males, however, has not been established. We report the successful treatment of a male with locally advanced breast cancer using the aromatase inhibitor letrozole.

• Authors: Brent P Zabolotny, Christian V Zalai, Sarkis H Meterissian
• Journal: Journal of surgical oncology (J Surg Oncol) Vol. 90 Issue 1 Pg. 26-30 (Apr 01 2005) ISSN: 0022-4790 [Print] United States
• PMID: 15786432 (Publication Type: Case Reports, Journal Article, Review)
• Copyright: (c) 2005 Wiley-Liss, Inc.

Chemical References

• Antineoplastic Agents
• Antineoplastic Agents, Hormonal
• Aromatase Inhibitors
• Nitriles
• Triazoles
• Letrozole

Topics

• Aged
• Antineoplastic Agents (therapeutic use)
• Antineoplastic Agents, Hormonal (therapeutic use)
• Aromatase Inhibitors (therapeutic use)
• Breast Neoplasms, Male (drug therapy)
• Carcinoma, Ductal, Breast (drug therapy)
• Humans
• Letrozole
• Male
• Nitriles (therapeutic use)
• Triazoles (therapeutic use)